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Clinical Research
Socioeconomic Status and Clinical Stage of
Patients Presenting for Treatment of Chronic
Venous Disease
Abdul Kader Natour,1 Ali Rteil,1 Paul Corcoran,1 Mitchell Weaver,1 Syed Ahsan,2 and
Loay Kabbani1

Objectives: The association between socioeconomic status (SES) and chronic venous
insufﬁciency has not been rigorously studied. This study aimed to determine the inﬂuence of
SES on the clinical stage of patients presenting for chronic venous disease therapy.
Methods: We performed a retrospective study of a prospectively collected data from the
Vascular Quality Initiative Varicose Vein Registry at our tertiary referral center. Medical records
of patients who underwent therapy for chronic venous disease between January 2015 and June
2019 were queried. SES was quantiﬁed using the neighborhood deprivation index (NDI), which
summarizes 8 domains of socioeconomic deprivation and is based on census tract data derived
from the patients’ addresses at the time of the treatment. High NDI scores correspond with lower
SES. The association between SES and severity of vein disease at presentation was assessed
with bivariate analysis of variance and linear regression analysis.
Results: A total of 449 patients with complete SES and clinical-etiology-anatomypathophysiology (CEAP) class data were included in the study. The mean age was 58
years, 67% were female, and 60% were White. CEAP classes were distributed as follows C2,
22%; C3, 50%; C4, 15%; C5, 5%; and C6, 8%. Patients with lower SES (higher NDI score)
tended to have a higher CEAP class at presentation (P < 0.05). SES was not associated with
history of deep venous thrombosis, use of compression therapy, or venous clinical severity
score.
Conclusions: At our institution, patients with more advanced venous disease tended to belong
to a lower SES group. This may reﬂect that patient with a lower SES have a longer time to
presentation due to delay in seeking medical help for venous disease.

Previous Presentation: This study was presented as an oral
presentation at the 2020 American Venous Forum 32nd Annual Meeting,
Amelia Island, FL, March 3-6, 2020.
1 Division of Vascular Surgery, Henry Ford Hospital, Detroit, MI
2 Division of Vascular Medicine, Henry Ford Hospital, Detroit, MI
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neighborhood deprivation index; SES, socioeconomic status.
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INTRODUCTION
In the United States, approximately 25–40% of
women and 10–20% of men have chronic venous
disease (CVD).1 Additionally, it has been reported
that 23% of adults have varicose veins, affecting 11
million men and 22 million women between the
ages of 40 and 80 years.2 , 3 The high prevalence of
CVD and cost associated with treatment especially
in its advanced stages make this disease a significant
burden on healthcare resources.4 Treating CVD
costs an estimated $3 billion per year in the United
States.5 This health care burden will continue to
rise as the population of older adults grows and
the prevalence of obesity increases.6 Moreover, the
incidence of varicose veins has been reported at 4–
5%, the disease progression rate has been shown
to be about 4%, and interventions for CVD are
expected to increase by 60% between 2013 and
2021, all indicating a continuous increase in the
CVD health care burden.6 In 2018, more than 38
million Americans lived below the poverty line,
and 8.5% of the population were uninsured.7 This
problem is amplified in the city of Detroit, where
nearly 38% of inhabitants live in poverty.8 Low
socioeconomic status (SES) has been shown to be
associated with increased morbidity and mortality
in cardiovascular patients,9 increased risk of deep
venous thrombosis,10 delayed access to health care,
and decreased access to specialized treatments
and procedures.11 , 12 To our knowledge, no studies
have looked at the association between SES and
advanced stage presentation of CVD. This study aims
to determine the influence of SES on the clinical
stage of patients presenting for CVD therapy.

MATERIALS AND METHODS
The Vascular Quality Initiative Varicose Vein
Registry at our tertiary referral center was queried
to identify all patients who underwent therapy
for CVD (stab phlebectomies, venous ablations)
between January 2015 and June 2019. The
patients come from local communities around
our vein clinics situated in several locations in
southeast Michigan. This study was approved by
our institutional review board and conducted in
accordance with the Health Insurance Portability
and Accountability Act and the prevailing ethical
principles governing research. Patient informed
consent was waived.
Sociodemographic variables identified included
gender, age, body mass index, and race/ethnicity
(African American, White, Asian, and other).
Exposure variables included preoperative use of
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Table I. Categorization of the cohort into Messer
Indexa Quintiles and CEAP classes
Quintile

NDI quintile

Cohort, N (%)

1
2
3
4
5
CEAP Class
C2
C3
C4
C5
C6

-1.59, -0.16
-0.16, 1.26
1.26, 2.69
2.69, 4.11
4.11, 5.54
CEAP Explanation
Varicose veins
Edema
Skin damage
Healed venous leg ulcer
Venous leg ulcer

226 (50.4)
164 (36.4)
54 (12.0)
5 (1.2)
0 (0.0)
Cohort, N (%)
98 (21.8)
226 (50.3)
67 (14.9)
23 (5.1)
35 (7.8)

a Messer

Index: Otherwise known as the neighborhood
deprivation index (NDI), the Messer Index reflects the
socioeconomic status of patients, with higher score indicating
lower socioeconomic status.

compression stockings, history of deep venous
thrombosis, venous clinical severity score, and the
clinical-etiology-anatomy-pathophysiology (CEAP)
classification. Deep vein thrombosis was confirmed
by history and physical exam performed by the
attending physician at the time of presentation.
Messer Neighborhood Deprivation Index
The neighborhood deprivation index (NDI) was
used to measure SES. The NDI is based on census
tract data derived from patients’ addresses at
the time of operation. This is a standardized
and reproducible index that summarizes 8
socioeconomic variables, including the percentage
of households that had the following characteristics:
head of household had less than a high school
education; head of household was male with a
professional occupation; head of household was
unemployed; head of household was a woman
with dependent children; household income was
below the 1999 federal poverty level; household
was considered crowded; household had an
annual income of <$30,000; and household
was on public assistance. The NDI represents
6 social domains: poverty housing, occupation,
employment, education, residential stability, and
racial composition. The NDI is calculated and a
score is given to each individual ranging from -1.59
to 5.54. The index is traditionally categorized into
quintiles, with the fifth quintile corresponding to
the most socioeconomically challenged (Table I). In
our data, there were too few patients in quintiles 4
and 5 to list separately. The NDI has been used in
several studies to study the effect of SES.13-15
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CEAP Classification
CVD severity was quantified using the CEAP
classification. This is a comprehensive classification
system that was developed to allow uniform
diagnosis and comparison of CVD patient
populations.16 , 17 The CEAP classification includes 7
clinical categories ranging from no visible signs of
venous disease (C0) to active venous ulcer (C6). In
our study, patients with CEAP classes of C2 to C6
were included (Table I).
Data Analysis
SES variables were combined and standardized
to increase interpretability of the models prior
to the analyses. Specifically, income-related
SES variables were set to present increases of
$10,000, and all other SES variables were set
to present increases of 10%. Pearson chi-square
test or Fisher exact test were performed for the
categorical variables. Independent t-test was used
for continuous variables. The association between
SES and CEAP was studied using bivariate analysis
of variance and linear regression analysis. Similarly,
the association between SES, demographics, and
exposure variables was assessed using multivariate
linear regression. SPSS version 27.0 was used for
statistical analysis (SPSS, Armonk, NY), and a P
value <0.05 was considered statistically significant.

RESULTS
Characteristics of the Study Cohort
CVD was identified in 493 patient records, 449
of which contained complete SES and CEAP
data. Baseline characteristics for the cohort are
summarized in Table II. The average age of these
patients was 58 years, 67% were female, and
60% were White. Compression stockings were
used by 92% of patients. History of deep venous
thrombosis and superficial thrombophlebitis was
present in 8% and 7% of the patients, respectively.
Prior varicose vein treatment was documented in
32% of the cohort, and 8% of the patients were
maintained on chronic anticoagulants. The average
venous clinical severity score was 8.3. The average
median household income was $51,300; 11.6%
were below poverty level; and 21% had at most
a high school diploma. The average NDI was 0.03
and the distribution of patients among quintiles is
shown in Table I. At presentation, CEAP classes
were as follows: C2, 22%; C3, 50%; C4, 15%; C5,
5%; and C6, 8% (Table I). Almost all the patients
had some sort of insurance (Table II). The average
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number of primary care office visits was 22/year
(includes internal medicine, geriatric medicine,
family medicine, and obstetrics and gynecology)
with a range of 0–116/year. Patients with more
severe CVD on presentation were more likely to live
closer to the hospital (P = 0.03; Fig. 1).
SES and Disease Severity at Presentation
The mean NDI did not correlate with gender
(P = 0.875). SES significantly differed among ethnic
groups, with African Americans having the highest
NDI (least affluent) (P < 0.001) (Table III). Use of
compression stockings and history of deep venous
thrombosis did not correlate with NDI (P = 0.171
and P = 0.636, respectively). Venous clinical
severity score was not associated with NDI (95%
CI, -0.007 to 0.031; P = 0.218). Univariate analysis
showed that affluent patients (lower NDI) had
significantly more prior varicose vein treatments
(P = 0.03). This association did not persist in the
multivariate linear regression model (Table IV).
An inverse linear correlation was seen between
the CEAP class at presentation and median
household income (P < 0.05; Fig. 2). Likewise,
there was a linear correlation between the CEAP
class at presentation and the NDI (P < 0.05; Fig. 3).

DISCUSSION
This study analyzed the association of SES with
the severity of CVD at presentation in a general
population-based sample in the United States. As
with other diseases, we found that lower SES
was significantly associated with more severe CVD
presentation. In our study, all patients had some
sort of insurance and nearly all of them had access
to a primary care physician. Our results suggest
that the delay in presentation may not be related
to access to healthcare, but may be related to lack
of education, lower health literacy, or increased
health neglect. Conversely, patients with higher SES
tended to present with a lower CEAP disease class
and tended to have had a higher number of previous
venous procedures. This may reflect those patients
with a higher SES may have access to better health
care and seek medical therapy earlier in the disease
process.
The incidence and prevalence of CVD are
increasing. The two main risk factors for CVD are
obesity and age.6 Thus, with the trend of increased
longevity in the general population and the growing
prevalence of obesity, the burden of CVD is
expected to significantly increase over the upcoming
years.6 This increasing CVD health care expenditure
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Table II. Demographics summary of the cohort
Variable
Demographics

All patients (N = 449)

Age, years, mean ± SD
Female, N (%)
White, N (%)
African American, N (%)
Body mass index, mean ± SD
Socioeconomic variables
Median household income (in $1000), mean ± SD
Percentage below poverty
Messer indexa
High school graduate, %
Insurance, N (%)
Medicare
Medicaid
Private
Any insurance
Exposure
Chronic anticoagulation, N (%)
Venous Clinical Severity Score, mean ± SD
Use of compression, N (%)
History of deep venous thrombosis, N (%)
History of superficial thrombophlebitis, N (%)
Prior varicose vein treatment, N (%)

58.4 ± 12.5
303 (67.5)
270 (60.5)
124 (27.8)
33.0 ± 7.7
51.3 ± 25.9
11.6 ± 11.3
0.03 ± 0.89
21.0 ± 12.3
69 (15.6)
36 (8.1)
338 (76.3)
443 (98.7)
34 (7.7)
8.3 ± 4.4
402 (91.8)
35 (7.9)
29 (6.6)
143 (32.4)

SD, standard deviation.
a Messer Index: Otherwise known as the neighborhood deprivation index, the
Messer Index reflects the socioeconomic status of patients, with higher score
indicating lower socioeconomic status.

Table III. Differences in mean NDI among demographic and exposure variables
Variable
Demographics

Mean NDI ± SD

P-value

Gender (Male; Female)
Race
Asian
African American
White
Other
Exposure
Chronic anticoagulation (No; Yes)
Use of compression stockings (No; Yes)
History of deep venous thrombosis (No; Yes)
History of superficial thrombophlebitis (No; Yes)
Prior varicose vein treatment (No; Yes)

0.04 ± 0.83; 0.03 ± 0.92

0.87
<0.001

-0.83 ± 0.30
0.66 ± 0.82
-0.28 ± 0.77
0.15 ± 0.83
0.01 ± 0.88; 0.03 ± 0.84
0.22 ± 0.96; -0.002 ± 0.876
0.02 ± 0.89; 0.09 ± 0.84
0.01 ± 0.88; 0.13 ± 0.95
0.09 ± 0.91; -0.12 ± 0.82

0.90
0.17
0.64
0.53
0.03

NDI, neighborhood deprivation index; SD, standard deviation.

makes early detection and treatment particularly
important for reducing patient suffering, improving
quality of life, and reducing health care costs.
Without treatment, most patients with CVD are
prone to disease progression. In the Bonn Vein
Study, 32% of C2 patients with saphenous varicose
veins progressed to stages C3-C6 within 6 years.18

In the Edinburgh Vein Study, 57.8% of 334 CVD
patients had progressed to a higher CEAP class or
developed new varicose veins after a mean followup period of 13.4 years, with an annual progression
rate of 5%.19 One study showed that 0.5% of
all patients with CVD have active venous ulcers,
costing around $10,500 annually in combined
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Fig. 1. Chart comparing median distance from the hospital according to CEAP Score. Abbreviations: CEAP, Clinical,
Etiology, Anatomy, and Pathophysiology.

Table IV. Multivariate linear regression model for NDI in the study population
Variables

Age (years)
Prior VVT
White
African American
Asian
Unknown/Other

Unstandardized coefficients

Standardized coefficients

95% CI for B

P
value

B

SE

Beta

Lower bound

Upper bound

-0.004
-0.059
ref
0.892
-0.548
0.368

0.003
0.086

-0.063
-0.031

-0.011
-0.228

0.002
0.109

0.16
0.49

0.091
0.397
0.134

0.456
-0.062
0.126

0.714
-1.330
0.104

1.070
0.233
0.632

<0.001
0.17
0.006

NDI, neighborhood deprivation index; ref, reference variable; SE, standard error; VVT, varicose vein treatment.

Fig. 2. Chart comparing median household income according to CEAP Score. Abbreviations: CEAP, Clinical, Etiology,
Anatomy, and Pathophysiology.
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Fig. 3. Chart comparing NDI according to CEAP Score. Abbreviations: CEAP, Clinical, Etiology, Anatomy, and
Pathophysiology; NDI, neighborhood deprivation index.

patient and health insurer cost.20 Furthermore, for
patients who experience increasing CVD severity,
ulcer development can occur in up to 25% of
these patients across the course of their illness.21 In
severe cases, CVD has led to limb loss.22–25 Another
study indicated that in the Western world, the
management of leg ulcers may consume up to 1%
of total health care costs.26
Treatment for CVD is multimodal and includes
conservative (e.g., stockings and bandages) and
interventional (e.g., venous drugs, sclerotherapy,
and surgery) therapies.4 The prevalence of
treatment increases with disease severity, from
2.7% in C0 patients to 96% in C5/C6 patients.4
The proportional increase in total cost for CVD
care with increasing disease severity is due to
the higher number of hospitalizations, surgical
procedures, medications, and other multilevel
treatment models used in more advanced disease.
Although some risk factors for the development
and progression of CVD are unmodifiable (e.g.,
age, female gender, and family history), other
factors can be mitigated through lifestyle changes
(e.g., physical activity, smoking cessation, and
weight loss).27 There is ample evidence in
the literature to show that appropriate early,
conservative, and interventional treatment for
CVD can significantly delay or prevent disease
progression and provide a highly cost-effective
use of health care resources.27 , 28 Therefore, early
management of patients presenting with CVD could
help limit the number of patients who progress
to severe CVD, which is the population that

incurs the main proportion of the CVD health care
burden.6
SES has been defined in multiple ways in
the literature.13 , 15 , 29 , 30 Owing to the numerous
parameters that can be used to describe SES, no
single variable can be all inclusive for quantifying
this measurement. Rather, SES is a concept that
encompasses multiple societal factors, including
income, wealth, occupation, and educational
status.31 In our analysis, we used a composite
score to quantify SES that encompassed several
variables, including median household income,
educational level, family income, percentage of
people below the poverty level, and the NDI.32
Our composite score minimized the limitations of
using a single variable to predict SES. Initially, NDI
had been used to explore the association of SES
with low birth weight.33 NDI has also been used to
show that low SES is associated with up to 37%
decreased probability of individuals participating
in health checks.34 Another study has shown
that patients with low SES, as defined by a high
NDI, were more likely to inappropriately use the
Emergency Department as a primary destination
for urgent health care instead of using a primary
care physician’s office.35 Patients with high NDI
also have been shown to have a lower likelihood
of achieving long-term cessation of opiate and
cocaine injection.15 Finally, patients with high
NDI have been shown to be more likely to have
unhealthy weight and have a higher prevalence of
adverse health behaviors such as smoking, physical
inactivity, and unhealthy diet, which could explain
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the increased risk of colon cancer in this group.14 In
our study, we showed that patients with high NDI
were significantly more likely to present with more
severe CVD as defined by the CEAP classification.
This may reflect those patients with a higher SES
may have access to better health care, or that they
seek medical therapy earlier in the disease process.
There may be a multitude of explanations for
why patients with low SES have advanced CVD
stage presentation. The relationship between lower
SES and delayed access to health care has been
shown in multiple studies.36–41 Lower education has
been shown to be strongly related to poor health
literacy, which is in turn an important risk factor
for delay in seeking medical care and worse health
outcomes.39 In our cohort, patients with higher NDI
were less likely to be high school graduates (P <
0.001), which might reflect poorer health literacy
and a decreased level of seeking medical care. In
addition, other studies have shown that patients
with lower SES tend to be diagnosed at more
advanced gastrointestinal tumor stages because of
unequal access to health care.40 Moreover, patients
with low SES tend to experience barriers to effective
treatment, such as financial burden, inadequate
insurance coverage, and lack of access to effective
therapy.41 This association may contribute to the
poorer health outcomes experienced by less affluent
patients and highlights the need for a multifaceted
approach to addressing health equity for low SES
patients that targets health care providers and the
health care system as a whole.37 In our study, most
patients had access to a primary care physician,
the entire patient population had some sort of
insurance, and patients with more severe CVD were
more likely to live closer to the hospital. This may
suggest that the delay to CVD presentation might
be better explained by lack of education, medical
knowledge, or motivation to follow-up rather than
lack of access to health care. Further research is
needed to extract the reasons for possible delay in
seeking medical care for CVD in patients with low
SES.
Limitations
This study is retrospective in nature which
allows determination of only association and
not causation, and variables analyzed were
limited to those recorded. In addition, an inherent
selection bias existed since we are a referral center.
Generalizability is limited since this study is not
population based. We did not conduct personal
interviews with patients, which may have better
corroborated their home locations, SES, prior
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medical treatment, and reasons for possible delay
in seeking medical care. Moreover, algorithms
based on patients’ census tract information were
used to estimate SES variables and hence were not
collected individually, which might have distorted
some associations. Finally, the time frame for
CVD presentation extended over several years.
Therefore, the patients’ neighborhoods and zip
code designated areas might have changed over
time with regard to their SES parameters.

CONCLUSION
Patients with lower SES tend to present with more
advanced venous disease to our tertiary referral
center. This reflects a delay in seeking proper
treatment. This may be due to lack of medical
education, or lack of access to proper health care.
Further studies are needed to elucidate the cause of
this delay in treatment. Understanding what drives
health care disparities is needed for improving
access to quality health care and making it more
equitable.
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